PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma

Katrin Schaper-Gerhardt^*, Steven Okoye, Rudolf Herbst, Jens Ulrich, Patrick Terheyden, Claudia Pföhler, Jochen S. Utikal, Alexander Kreuter, Peter Mohr, Edgar Dippel, Imke Satzger, Antje Sucker, Dirk Schadendorf, Selma Ugurel, Ralf Gutzmer

^*Corresponding author for this work